LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | GR_AOC |
|---|---|---|
| MCF 10A | SU11274 | 0.1507 |
| MCF 10A | Fedratinib | 0.2356 |
| MCF 10A | TGX221 | 0.0974 |
| MCF 10A | Torin1 | 0.7775 |
| MCF 10A | Torin2 | 0.9104 |
| MCF 10A | Tozasertib | 0.8650 |
| MCF 10A | Trametinib | 0.8020 |
| MCF 10A | TWS119 | 0.1025 |
| MCF 10A | Vemurafenib | 0.1109 |
| MCF 10A | WH-4-025 | 0.3754 |
| MCF 10A | Withaferin A | 0.6151 |
| MCF 10A | WYE-125132 | 0.7700 |
| MCF 10A | WZ-4-145 | 0.2338 |
| MCF 10A | WZ3105 | 1.0525 |
| MCF 10A | XL147 | 0.0857 |
| MCF 10A | XMD11-50 | 0.3270 |
| MCF 10A | XMD11-85h | 0.0541 |
| MCF 10A | XMD16-144 | 0.7522 |
| MCF 10A | Y39983 | 0.1847 |
| MCF 10A | YM 201636 | 0.1726 |
| MCF 10A | ZSTK474 | 0.4278 |
| MCF7 | Seliciclib | 0.1989 |
| MCF7 | A443654 | 1.2282 |
| MCF7 | Afatinib | 0.3327 |
| MCF7 | AT-7519 | 1.1212 |